• 1233 Citations
20052021
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Training Experience

2001Residency, Rush University Medical Center
2004Fellowship, Rush University Medical Center

Education/Academic qualification

MD, Rush Medical College

… → 1998

Fingerprint Dive into the research topics where Victoria Meucci Villaflor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Induction Chemotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2017 2021

Research Output 2005 2019

  • 1233 Citations
  • 39 Article
  • 8 Review article
  • 1 Chapter
  • 1 Comment/debate
3 Citations (Scopus)

Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti–PD-1/PD-L1 Therapy in Non–Small-Cell Lung Cancer

Chae, Y. K., Davis, A. A., Raparia, K., Agte, S., Pan, A., Mohindra, N. A., Villaflor, V. M. & Giles, F., Mar 1 2019, In : Clinical Lung Cancer. 20, 2, p. 88-96.e6

Research output: Contribution to journalArticle

Tumor Burden
Non-Small Cell Lung Carcinoma
DNA Repair
Ligands
Mutation

Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer

Chae, Y. K., Davis, A. A., Agte, S., Pan, A., Simon, N. I., Iams, W. T., Cruz, M. R., Tamragouri, K., Rhee, K., Mohindra, N. A., Villaflor, V. M., Park, W., Lopes, G. & Giles, F. J., Jun 1 2019, In : Oncologist. 24, 6, p. 820-828 9 p.

Research output: Contribution to journalArticle

Tumor Burden
Non-Small Cell Lung Carcinoma
DNA
Neoplasms
Programmed Cell Death 1 Receptor
5 Citations (Scopus)

Optima: A phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Seiwert, T. Y., Foster, C. C., Blair, E. A., Karrison, T. G., Agrawal, N., Melotek, J. M., Portugal, L., Brisson, R. J., Dekker, A., Kochanny, S., Gooi, Z., Lingen, M. W., Villaflor, V. M., Ginat, D. T., Haraf, D. J. & Vokes, E. E., Feb 1 2019, In : Annals of Oncology. 30, 2, p. 297-302 6 p.

Research output: Contribution to journalArticle

Oropharyngeal Neoplasms
Chemoradiotherapy
Radiotherapy
Induction Chemotherapy
Clinical Trials
1 Citation (Scopus)

Complexity of Delivering Precision Medicine: Opportunities and Challenges

Davis, A. A., McKee, A. E., Kibbe, W. A. & Villaflor, V. M., May 23 2018, In : American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 38, p. 998-1007 10 p.

Research output: Contribution to journalReview article

Precision Medicine
Information Dissemination
Clinical Trials
Neoplasms
Therapeutics

Correction: Axl is a logical molecular target research in head and neck squamous cell carcinoma (Clin Cancer Res) (2018) 21 (2601–2612) DOI :10.1158/1078-0432.CCR-14-2648)

Brand, T. M., Iida, M., Stein, A. P., Corrigan, K. L., Braverman, C. M., Coan, J. P., Pearson, H. E., Bahrar, H., Fowler, T. L., Bednarz, B. P., Saha, S., Yang, D., Gill, P. S., Lingen, M. W., Saloura, V., Villaflor, V. M., Salgia, R., Kimple, R. J. & Wheeler, D. L., Dec 1 2018, In : Clinical Cancer Research. 24, 23, 1 p.

Research output: Contribution to journalComment/debate

Emotions
Antibodies
Research
Neoplasms
Carcinoma, squamous cell of head and neck